Abstract
Forty-five adult outpatients with endoscopically confirmed gastric ulceration completed a double-blind trial of either cimetidine (1 g/day) or placebo. After six weeks 18 of the 23 patients receiving cimetidine showed complete ulcer healing compared with only six of the 22 patients receiving placebo. The cimetidine group also had fewer days with pain than the placebo group but the difference was not statistically significant. Cimetidine therefore seems to promote healing of gastric ulcers without severe side effects, although its effect on pain is less pronounced than in patients with duodenal ulcers.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bodemar G., Walan A. Cimetidine in the treatment of active duodenal and prepyloric ulcers. Lancet. 1976 Jul 24;2(7978):161–164. doi: 10.1016/s0140-6736(76)92342-4. [DOI] [PubMed] [Google Scholar]
- Gray G. R., Smith I. S., McKenzie I., Crean G. P., Gillespie G. Oral cimetidine in severe duodenal ulceration. A double-blind controlled trial. Lancet. 1977 Jan 1;1(8001):4–7. doi: 10.1016/s0140-6736(77)91650-6. [DOI] [PubMed] [Google Scholar]
- Gudmand-Höyer E., Frost F., Jensen K. B., Krag E., Rask-Madsen J., Rahbek I., Rune S., Wulff H. R. A pragmatic trial of cimetidine in duodenal ulcer patients. Scand J Gastroenterol. 1977;12(5):611–613. doi: 10.3109/00365527709181342. [DOI] [PubMed] [Google Scholar]